{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T16:04:37Z","timestamp":1783699477587,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T00:00:00Z","timestamp":1534723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100013347","name":"European Society of Intensive Care Medicine","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013347","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Swiss Society of Intensive Care Medicine"},{"name":"Privatdozenten Stiftung Universit\u00e4t Z\u00fcrich"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["ICMx"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s40635-018-0190-5","type":"journal-article","created":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T13:12:18Z","timestamp":1534770738000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Heart rate elevations during early sepsis predict death in fluid-resuscitated rats with fecal peritonitis"],"prefix":"10.1186","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7943-7624","authenticated-orcid":false,"given":"Alain","family":"Rudiger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Jeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Arrigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian A.","family":"Schaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian F.","family":"Hildenbrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarete","family":"Arras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkhardt","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mervyn","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Schoedon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donat R.","family":"Spahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Bettex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,20]]},"reference":[{"key":"190_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M et al (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315:801\u2013810","journal-title":"JAMA"},{"key":"190_CR2","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","volume":"29","author":"DC Angus","year":"2001","unstructured":"Angus DC, Lindle-Zwirble WT, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303\u20131310","journal-title":"Crit Care Med"},{"key":"190_CR3","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/S2213-2600(14)70061-X","volume":"2","author":"JL Vincent","year":"2014","unstructured":"Vincent JL, Marshall JC, Namendys-Silva SA, Francois B, Martin-Loeches I, Lipman J et al (2014) Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit. Lancet Respir Med 2:380\u2013386","journal-title":"Lancet Respir Med"},{"key":"190_CR4","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1208623","volume":"369","author":"DC Angus","year":"2013","unstructured":"Angus DC, van der Poll T (2013) Severe sepsis and septic shock. N Engl J Med 369:840\u2013851","journal-title":"N Engl J Med"},{"key":"190_CR5","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1042\/CS20120334","volume":"124","author":"A Rudiger","year":"2013","unstructured":"Rudiger A, Dyson A, Felsmann K, Carre JE, Taylor V, Hughes S et al (2013) Early functional and transcriptomic changes in the myocardium predict outcome in a long-term rat model of sepsis. Clin Sci 124:391\u2013401","journal-title":"Clin Sci"},{"key":"190_CR6","doi-asserted-by":"publisher","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","volume":"8","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG (2010) Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol 8:e1000412","journal-title":"PLoS Biol"},{"key":"190_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/SHK.0b013e31825f396c","volume":"38","author":"P Reynolds","year":"2012","unstructured":"Reynolds P, Wall P, van Griensven M, McConnell K, Lang C, Buchman T (2012) Shock supports the use of animal research reporting guidelines. Shock 38:1\u20133","journal-title":"Shock"},{"key":"190_CR8","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1007\/s00134-011-2227-z","volume":"37","author":"A Dyson","year":"2011","unstructured":"Dyson A, Rudiger A, Singer M (2011) Temporal changes in tissue cardiorespiratory function during faecal peritonitis. Intensive Care Med 37:1192\u20131200","journal-title":"Intensive Care Med"},{"key":"190_CR9","doi-asserted-by":"publisher","first-page":"e821","DOI":"10.1097\/CCM.0000000000002381","volume":"45","author":"N Arulkumaran","year":"2017","unstructured":"Arulkumaran N, Sixma ML, Jentho E, Ceravola E, Bass PS, Kellum JA et al (2017) Sequential analysis of a panel of biomarkers and pathologic findings in a resuscitated rat model of sepsis and recovery. Crit Care Med 45:e821\u2013e830","journal-title":"Crit Care Med"},{"key":"190_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40635-017-0137-2","volume":"5","author":"V Jeger","year":"2017","unstructured":"Jeger V, Arrigo M, Hildenbrand FF, M\u00fcller D, Jirkof P, Hauffe T et al (2017) Improving animal welfare using continuous nalbuphine infusion in a long-term rat model of sepsis. Intensive Care Med Exp 5:17","journal-title":"Intensive Care Med Exp"},{"key":"190_CR11","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1177\/0023677216675009","volume":"50","author":"V Jeger","year":"2016","unstructured":"Jeger V, Hauffe T, Nicholls-Vuille F, Bettex D, Rudiger A (2016) Analgesia in clinically relevant rodent models of sepsis. Lab Anim 50:418\u2013426","journal-title":"Lab Anim"},{"key":"190_CR12","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1164\/ajrccm.164.5.2010073","volume":"164","author":"SM Hollenberg","year":"2001","unstructured":"Hollenberg SM, Dumasius A, Easington C, Colilla SA, Neumann A, Parrillo JE (2001) Characterization of a hyperdynamic murine model of resuscitated sepsis using echocardiography. Am J Respir Crit Care Med 164:891\u2013895","journal-title":"Am J Respir Crit Care Med"},{"key":"190_CR13","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/oxfordjournals.eurheartj.a014868","volume":"17","author":"Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology","year":"1996","unstructured":"Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (1996) Heart rate variability - standards of measurement, physiological interpretation, and clinical use. Eur Heart J 17:354\u2013381","journal-title":"Eur Heart J"},{"key":"190_CR14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s12012-007-0004-6","volume":"7","author":"WH Rowan","year":"2007","unstructured":"Rowan WH, Campen MJ, Wichers LB, Watkinson WP (2007) Heart rate variability in rodents: uses and caveats in toxicological studies. Cardiovasc Toxicol 7:28\u201351","journal-title":"Cardiovasc Toxicol"},{"key":"190_CR15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/CCM.0b013e318232e50c","volume":"40","author":"SA Magder","year":"2012","unstructured":"Magder SA (2012) The ups and downs of heart rate. Crit Care Med 40:239\u2013245","journal-title":"Crit Care Med"},{"key":"190_CR16","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1093\/eurheartj\/ehl259","volume":"27","author":"S Cook","year":"2006","unstructured":"Cook S, Togni M, Schaub MC, Wenaweser P, Hess OM (2006) High heart rate: a cardiovascular risk factor? Eur Heart J 27:2387\u20132393","journal-title":"Eur Heart J"},{"key":"190_CR17","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1097\/00003246-198710000-00006","volume":"15","author":"MM Parker","year":"1987","unstructured":"Parker MM, Shelhamer JH, Natanson C, Alling DW, Parrillo JE (1987) Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis. Crit Care Med 15:923\u2013929","journal-title":"Crit Care Med"},{"key":"190_CR18","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0300-9572(86)90068-7","volume":"14","author":"G Azimi","year":"1986","unstructured":"Azimi G, Vincent J-L (1986) Ultimate survival from septic shock. Resuscitation 14:245\u2013253","journal-title":"Resuscitation"},{"key":"190_CR19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/01.CCM.0000150028.64264.14","volume":"33","author":"O Sander","year":"2005","unstructured":"Sander O, Welters ID, Foex P, Sear JW (2005) Impact of prolonged elevated heart rate on incidence of major cardiac events in critically ill patients with a high risk of cardiac complications. Crit Care Med 33:81\u201388 discussion 241-242","journal-title":"Crit Care Med"},{"key":"190_CR20","first-page":"S89","volume":"40","author":"R Domizi","year":"2014","unstructured":"Domizi R, Calcinaro S, Beilstein C, Boerma C, Ciche J-D, D'Egidio AD et al (2014) Relationship between catecholamine dose, tachycardia and outcome in septic shock: a multicentre evaluation (meeting abstract 0300). Intensive Care Med 40:S89","journal-title":"Intensive Care Med"},{"key":"190_CR21","doi-asserted-by":"publisher","first-page":"S512","DOI":"10.1097\/CCM.0b013e3181f23dc4","volume":"38","author":"AC Lukaszewicz","year":"2010","unstructured":"Lukaszewicz AC, Payen D (2010) The future is predetermined in severe sepsis, so what are the implications? Crit Care Med 38:S512\u2013S517","journal-title":"Crit Care Med"},{"key":"190_CR22","doi-asserted-by":"publisher","first-page":"e167","DOI":"10.1371\/journal.pmed.0020167","volume":"2","author":"M Singer","year":"2005","unstructured":"Singer M, Glynne P (2005) Treating critical illness: the importance of first doing no harm. PLoS Med 2:e167","journal-title":"PLoS Med"},{"key":"190_CR23","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1164\/ajrccm.160.2.9810073","volume":"160","author":"D Annane","year":"1999","unstructured":"Annane D, Trabold F, Sharshar T, Jarrin I, Blanc AS, Raphael J-C et al (1999) Inappropriate sympathetic activation at onset of septic shock: a spectral analysis approach. Am J Respir Crit Care Med 160:458\u2013465","journal-title":"Am J Respir Crit Care Med"},{"key":"190_CR24","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1161\/01.CIR.95.6.1449","volume":"95","author":"P van de Borne","year":"1997","unstructured":"van de Borne P, Montano N, Pagani M, Oren R, Somers VK (1997) Absence of low-frequency variability of sympathetic nerve activity in severe heart failure. Circulation 95:1449\u20131454","journal-title":"Circulation"},{"key":"190_CR25","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1097\/00003246-200107000-00013","volume":"29","author":"M Korach","year":"2001","unstructured":"Korach M, Sharshar T, Jarrin I, Fouillot JP, Raphael JC, Gajdos P et al (2001) Cardiac variability in critically ill adults: influence of sepsis. Crit Care Med 29:1380\u20131385","journal-title":"Crit Care Med"},{"key":"190_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1006\/jsre.1996.0214","volume":"63","author":"RJ Winchell","year":"1996","unstructured":"Winchell RJ, Hoyt DB (1996) Spectral analysis of heart rate variability in the ICU: a measure of autonomic function. J Surg Res 63:11\u201316","journal-title":"J Surg Res"},{"key":"190_CR27","doi-asserted-by":"publisher","first-page":"e0180060","DOI":"10.1371\/journal.pone.0180060","volume":"12","author":"FM de Castilho","year":"2017","unstructured":"de Castilho FM, Ribeiro ALP, da Silva JLP, Nobre V, de Sousa MR (2017) Heart rate variability as predictor of mortality in sepsis: a prospective cohort study. PLoS One 12:e0180060","journal-title":"PLoS One"},{"key":"190_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.autneu.2007.10.006","volume":"138","author":"JA Pancoto","year":"2008","unstructured":"Pancoto JA, Correa PB, Oliveira-Pelegrin GR, Rocha MJ (2008) Autonomic dysfunction in experimental sepsis induced by cecal ligation and puncture. Auton Neurosci 138:57\u201363","journal-title":"Auton Neurosci"},{"issue":"Suppl 5","key":"190_CR29","doi-asserted-by":"crossref","first-page":"S669","DOI":"10.33549\/physiolres.933226","volume":"64","author":"I Zila","year":"2015","unstructured":"Zila I, Mokra D, Kopincova J, Kolomaznik M, Javorka M, Calkovska A (2015) Heart rate variability and inflammatory response in rats with lipopolysaccharide-induced endotoxemia. Physiol Res 64(Suppl 5):S669\u2013S676","journal-title":"Physiol Res"},{"key":"190_CR30","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1097\/shk.0b013e3180638d1","volume":"28","author":"Y Tateishi","year":"2007","unstructured":"Tateishi Y, Oda S, Nakamura M, Watanabe K, Kuwaki T, Moriguchi T et al (2007) Depressed heart rate variability is associated with high IL-6 blood level and decline in the blood pressure in septic patients. Shock 28:549\u2013553","journal-title":"Shock"},{"key":"190_CR31","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/nature01260","volume":"420","author":"TG Buchman","year":"2002","unstructured":"Buchman TG (2002) The community of the self. Nature 420:246\u2013251","journal-title":"Nature"},{"key":"190_CR32","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1097\/01.CCM.0000114827.93410.D8","volume":"32","author":"J Charpentier","year":"2004","unstructured":"Charpentier J, Luyt C-E, Fulla Y, Visonneau C, Cariou A, Grabar S et al (2004) Brain natriuretic peptide: a marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med 32:660\u2013665","journal-title":"Crit Care Med"},{"key":"190_CR33","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1097\/01.CCM.0000229144.97624.90","volume":"34","author":"A Rudiger","year":"2006","unstructured":"Rudiger A, Gasser S, Fischler M, Hornemann T, Von Eckardstein A, Maggiorini M (2006) Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure. Crit Care Med 34:2140\u20132144","journal-title":"Crit Care Med"},{"key":"190_CR34","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1097\/CCM.0b013e31818b9153","volume":"36","author":"F Post","year":"2008","unstructured":"Post F, Weilemann LS, Messow CM, Sinning C, Munzel T (2008) B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients. Crit Care Med 36:3030\u20133037","journal-title":"Crit Care Med"},{"key":"190_CR35","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1097\/SHK.0000000000000673","volume":"46","author":"N Hayase","year":"2016","unstructured":"Hayase N, Yamamoto M, Asada T, Isshiki R, Yahagi N, Doi K (2016) Association of heart rate with N-terminal pro-B-type natriuretic peptide in septic patients: a prospective observational cohort study. Shock 46:642\u2013648","journal-title":"Shock"},{"key":"190_CR36","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1016\/j.jss.2011.05.019","volume":"170","author":"FA Gonnert","year":"2011","unstructured":"Gonnert FA, Recknagel P, Seidel M, Jbeily N, Dahlke K, Bockmeyer CL et al (2011) Characteristics of clinical sepsis reflected in a reliable and reproducible rodent sepsis model. J Surg Res 170:e123\u2013e134","journal-title":"J Surg Res"},{"key":"190_CR37","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/00005344-199810000-00012","volume":"32","author":"L Mangin","year":"1998","unstructured":"Mangin L, Swynghedauw B, Benis A, Thibault N, Lerebours G, Carre F (1998) Relationships between heart rate and heart rate variability: study in conscious rats. J Cardiovasc Pharmacol 32:601\u2013607","journal-title":"J Cardiovasc Pharmacol"},{"key":"190_CR38","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/B978-0-444-63274-6.00010-2","volume":"209","author":"TE Dick","year":"2014","unstructured":"Dick TE, Hsieh YH, Dhingra RR, Baekey DM, Galan RF, Wehrwein E et al (2014) Cardiorespiratory coupling: common rhythms in cardiac, sympathetic, and respiratory activities. Prog Brain Res 209:191\u2013205","journal-title":"Prog Brain Res"},{"key":"190_CR39","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/2197-425X-1-6","volume":"1","author":"PS Zolfaghari","year":"2013","unstructured":"Zolfaghari PS, Pinto BB, Dyson A, Singer M (2013) The metabolic phenotype of rodent sepsis: cause for concern? Intensive Care Med Exp 1:25","journal-title":"Intensive Care Med Exp"},{"key":"190_CR40","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1189\/jlb.5MR0315-127R","volume":"98","author":"PA Efron","year":"2015","unstructured":"Efron PA, Mohr AM, Moore FA, Moldawer LL (2015) The future of murine sepsis and trauma research models. J Leukoc Biol 98:945\u2013952","journal-title":"J Leukoc Biol"}],"container-title":["Intensive Care Medicine Experimental"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40635-018-0190-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40635-018-0190-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40635-018-0190-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T01:10:15Z","timestamp":1604797815000},"score":1,"resource":{"primary":{"URL":"https:\/\/icm-experimental.springeropen.com\/articles\/10.1186\/s40635-018-0190-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,20]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["190"],"URL":"https:\/\/doi.org\/10.1186\/s40635-018-0190-5","relation":{},"ISSN":["2197-425X"],"issn-type":[{"value":"2197-425X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,20]]},"assertion":[{"value":"23 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All protocols were approved by the Animal Experimentation Committee at the Veterinary Office of the Canton of Zurich, Switzerland. Principles of the 3Rs were implemented.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AR has received lecture fees for talks on esmolol, a short-acting beta-blocker, from OrphaSwiss GmbH and AMOMED, the distributors of nalbuphine in Switzerland and Europe. MS is a UK National Institute of Health Research Senior Investigator.DRS\u2019 academic department is\/has been receiving grant support from the Swiss National Science Foundation, Berne, Switzerland, the Ministry of Health (Gesundheitsdirektion) of the Canton of Zurich, Switzerland for Highly Specialized Medicine, the Swiss Society of Anesthesiology and Reanimation (SGAR), Berne, Switzerland, the Swiss Foundation for Anesthesia Research, Zurich, Switzerland, Bundesprogramm Chancengleichheit, Berne, Switzerland, CSL Behring, Berne, Switzerland, Vifor SA, Villars-sur-Gl\u00e2ne, Switzerland. DRS was the chair of the ABC Faculty and is the co-chair of the ABC-Trauma Faculty, managed by Physicians World Europe GmbH, Mannheim, Germany and sponsored by unrestricted educational grants from Novo Nordisk Health Care AG, Zurich, Switzerland, CSL Behring GmbH, Marburg, Germany and LFB Biom\u00e9dicaments, Courtaboeuf Cedex, France.In the past 5\u00a0years, DRS has received honoraria or travel support for consulting or lecturing from Abbott AG, Baar, Switzerland, AMGEN GmbH, Munich, Germany, AstraZeneca AG, Zug, Switzerland, Baxter AG, Volketswil, Switzerland, Baxter S.p.A., Roma, Italy, Bayer, Z\u00fcrich, Switzerland and Berlin, Germany, B. Braun Melsungen AG, Melsungen, Germany, Boehringer Ingelheim (Schweiz) GmbH, Basel, Switzerland, Bristol-Myers-Squibb, Rueil-Malmaison Cedex, France and Baar, Switzerland, CSL Behring GmbH, Hattersheim am Main, Germany and Berne, Switzerland, Curacyte AG, Munich, Germany, Daiichi Sankyo (Schweiz) AG, Thalwil, Switzerland, Danube University of Krems, Austria, Ethicon Biosurgery, Sommerville, New Jersey, USA, Fresenius SE, Bad Homburg v.d.H., Germany, Galenica AG, Bern, Switzerland (including Vifor SA, Villars-sur-Gl\u00e2ne, Switzerland), GlaxoSmithKline GmbH & Co. KG, Hamburg, Germany, Janssen-Cilag, Baar, Switzerland and Beerse, Belgium, LFB Biom\u00e9dicaments, Courtaboeuf Cedex, France, Merck Sharp & Dohme AG, Luzern, Switzerland, Novo Nordisk A\/S, Bagsv\u00e4rd, Denmark, Octapharma AG, Lachen, Switzerland, Organon AG, Pf\u00e4ffikon\/SZ, Switzerland, PAION Deutschland GmbH, Aachen, Germany, Pharmacosmos A\/S, Holbaek, Denmark, Photonics Healthcare B.V., Utrecht, Netherlands, ratiopharm Arzneimittel Vertriebs-GmbH, Vienna, Austria, Roche, Reinach, Switzerland, Sarstedt AG & Co., Sevelen, Switzerland, Schering-Plough International, Inc., Kenilworth, New Jersey, USA, Tem International GmbH, Munich, Germany, Verum Diagnostica GmbH, Munich, Germany, US Department of Defense, Washington, USA, Vifor Pharma, Munich, Germany, Vienna, Austria and St. Gallen, Switzerland.For the remaining authors, no relevant conflicts of interest or sources of funding were declared.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"28"}}